Like Japan, South Korea has yet to approve any vaccine, but has signed contracts with pharmaceutical companies for access to their vaccine candidates.
The country agreed to import doses for 6 million people from Janssen, owned by Johnson & Johnson. It will also import doses for 10 million people each from Pfizer, AstraZeneca, Moderna, and the global Covax initiative.
AstraZeneca is expected to be the first to receive approval, with an expedited approval and quality assurance process. The first vaccinations could roll out in February.
Janssen vaccinations could start in the second quarter, and Pfizer vaccines will arrive in the third quarter, according to the Prime Minister. He added that they are working to move up the Pfizer vaccine, to potentially the second quarter.
With enough doses secured for 44 million people, the government is aiming to vaccinate 80% of its population of 51 million people by November to reach herd immunity.